SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
TerrAscend Corp. (TRSSF) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+70.3%).
- Analyst consensus target $2.93 (+70.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — TRSSF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.99
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.29
Book Value / Share$0.00
Revenue / Share$0.87
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$2.93 (+70.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.03 |
$0.00 |
$-867.18K |
- |
| 2017 |
$-0.18 |
$0.00 |
$-6.81M |
- |
| 2018 |
$-0.24 |
$6.83M |
$-22.03M |
-322.7% |
| 2019 |
$-2.17 |
$84.87M |
$-215.79M |
-254.3% |
| 2020 |
$-1.04 |
$198.32M |
$-155.12M |
-78.2% |
| 2021 |
$0.02 |
$194.21M |
$12.63M |
6.5% |
| 2022 |
$-1.76 |
$247.83M |
$-303.96M |
-122.6% |
| 2023 |
$-0.33 |
$317.33M |
$-91.1M |
-28.7% |
| 2024 |
$-0.28 |
$306.68M |
$-72.67M |
-23.7% |
| 2025 |
$-0.29 |
$260.56M |
$-81.33M |
-31.2% |
